Skip to main content

Table 4 Outcome characteristics of patients with isolated pulmonary Candida spp. colonization without pre-existing pneumonia (cohort 2)

From: Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects

  Antifungal therapy (n = 44) No antifungal therapy (n = 131) p value
SOFA score (day 7) 7 (4; 10) 3 (1; 6) 0.003
Newly acquired pneumonia, n (%) 21 (47.7) 22 (16.8) <0.001
Sepsis/severe sepsis, n (%) 18 (40.9) 27 (20.6) 0.01
Mechanical ventilation (h) 162 (140; 547) 152 (59; 242) <0.001
Hospital stay (days) 31 (15; 53) 20 (10; 34) 0.004
ICU stay (days) 17 (10; 29) 7 (4; 12) <0.001
In-hospital mortality, n (%) 22 (50) 39 (29.8) 0.02
  1. Data are presented as median (25 %; 75 %) quartile
  2. SOFA Sequential Organ Failure Assessment